Immunology PhD from UNSW who worked in cellular therapy manufacturing before founding a biotech company focused on off-the-shelf engineered T cells. Sophie's previous role involved scaling production protocols at a South Australian contract manufacturer, giving her deep domain expertise. She's currently raising Series A to fund clinical trial preparation.